SG11202107978RA - Methods and system for the reconstruction of drug response and disease networks and uses thereof - Google Patents
Methods and system for the reconstruction of drug response and disease networks and uses thereofInfo
- Publication number
- SG11202107978RA SG11202107978RA SG11202107978RA SG11202107978RA SG11202107978RA SG 11202107978R A SG11202107978R A SG 11202107978RA SG 11202107978R A SG11202107978R A SG 11202107978RA SG 11202107978R A SG11202107978R A SG 11202107978RA SG 11202107978R A SG11202107978R A SG 11202107978RA
- Authority
- SG
- Singapore
- Prior art keywords
- reconstruction
- methods
- drug response
- disease networks
- networks
- Prior art date
Links
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B45/00—ICT specially adapted for bioinformatics-related data visualisation, e.g. displaying of maps or networks
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B5/00—ICT specially adapted for modelling or simulations in systems biology, e.g. gene-regulatory networks, protein interaction networks or metabolic networks
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B5/00—ICT specially adapted for modelling or simulations in systems biology, e.g. gene-regulatory networks, protein interaction networks or metabolic networks
- G16B5/10—Boolean models
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics
- G16B50/10—Ontologies; Annotations
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/50—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for simulation or modelling of medical disorders
Landscapes
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medical Informatics (AREA)
- General Health & Medical Sciences (AREA)
- Evolutionary Biology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Biophysics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Theoretical Computer Science (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Data Mining & Analysis (AREA)
- Databases & Information Systems (AREA)
- Bioethics (AREA)
- Physiology (AREA)
- Molecular Biology (AREA)
- Primary Health Care (AREA)
- Medicinal Chemistry (AREA)
- Artificial Intelligence (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Software Systems (AREA)
- Evolutionary Computation (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medical Treatment And Welfare Office Work (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962795710P | 2019-01-23 | 2019-01-23 | |
| US201962795705P | 2019-01-23 | 2019-01-23 | |
| PCT/US2020/014536 WO2020154356A1 (en) | 2019-01-23 | 2020-01-22 | Methods and system for the reconstruction of drug response and disease networks and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202107978RA true SG11202107978RA (en) | 2021-08-30 |
Family
ID=69724089
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202107994TA SG11202107994TA (en) | 2019-01-23 | 2020-01-22 | Pharmacogenomic decision support for modulators of the nmda, glycine, and ampa receptors |
| SG11202107978RA SG11202107978RA (en) | 2019-01-23 | 2020-01-22 | Methods and system for the reconstruction of drug response and disease networks and uses thereof |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202107994TA SG11202107994TA (en) | 2019-01-23 | 2020-01-22 | Pharmacogenomic decision support for modulators of the nmda, glycine, and ampa receptors |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US11984208B2 (en) |
| EP (2) | EP3915121A1 (en) |
| JP (2) | JP2022520009A (en) |
| CN (2) | CN113597645A (en) |
| AU (2) | AU2020210904A1 (en) |
| CA (2) | CA3127607A1 (en) |
| SG (2) | SG11202107994TA (en) |
| WO (2) | WO2020154362A1 (en) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20200357482A1 (en) * | 2019-05-06 | 2020-11-12 | MedWhatBio, Inc. | Method and system for automating curation of genetic data |
| US11741557B2 (en) * | 2020-01-01 | 2023-08-29 | Rockspoon, Inc. | Biomarker-based food item design system and method |
| US20220059204A1 (en) * | 2020-08-21 | 2022-02-24 | At&T Intellectual Property I, L.P. | System and method for secure monitoring and delivery of medications |
| CN112382385A (en) * | 2020-11-12 | 2021-02-19 | 山东中医药大学 | Aura-free migraine auxiliary diagnosis algorithm based on 3D convolutional neural network |
| CN114758722B (en) * | 2022-04-21 | 2024-06-28 | 湖南大学 | Gene sequence interpolation method based on generation type countermeasure network |
| CN115101120B (en) * | 2022-06-27 | 2024-04-16 | 山东大学 | Corn alternative splicing isomer function prediction system based on data fusion |
| WO2024144380A1 (en) * | 2022-12-30 | 2024-07-04 | 건국대학교 글로컬산학협력단 | Method and device for predicting new drug repurposing candidate by ensemble of matched weighted-connection score calculated using machine learning-based meta-analysis |
| CN116467596B (en) * | 2023-04-11 | 2024-03-26 | 广州国家现代农业产业科技创新中心 | Training method of rice grain length prediction model, morphology prediction method and apparatus |
| CN116959561B (en) * | 2023-09-21 | 2023-12-19 | 北京科技大学 | Gene interaction prediction method and device based on neural network model |
| CN117788465B (en) * | 2024-02-26 | 2024-05-28 | 中日友好医院(中日友好临床医学研究所) | Method and device for associating local cerebral blood flow graph with transcription and cell characteristics |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4776146B2 (en) | 2001-01-10 | 2011-09-21 | ザ・ペン・ステート・リサーチ・ファンデーション | Method and system for modeling cellular metabolism |
| US7585680B2 (en) * | 2003-08-28 | 2009-09-08 | Marshfield Medical Research And Education Foundation | Method and device for monitoring medication usage |
| CA2759563A1 (en) | 2009-04-20 | 2010-10-28 | Fox Chase Cancer Center | Rotamer libraries and methods of use thereof |
| MX2013001744A (en) * | 2010-08-13 | 2013-06-28 | Intellimedicine Inc | System and methods for the production of personalized drug products. |
| EP2608122A1 (en) | 2011-12-22 | 2013-06-26 | Philip Morris Products S.A. | Systems and methods for quantifying the impact of biological perturbations |
| EA201492178A1 (en) | 2012-05-22 | 2015-12-30 | Берг Ллк | CELLULAR BASED CROSS ANALYSIS FOR IDENTIFICATION OF MARKERS INDUCED BY TOXICITY MEDICINES |
| US20140274764A1 (en) | 2013-03-15 | 2014-09-18 | Pathway Genomics Corporation | Method and system to predict response to treatments for mental disorders |
| US10098854B2 (en) * | 2014-08-13 | 2018-10-16 | Janssen Pharmaceutica Nv | Method for the treatment of depression |
| US10249389B2 (en) | 2017-05-12 | 2019-04-02 | The Regents Of The University Of Michigan | Individual and cohort pharmacological phenotype prediction platform |
-
2020
- 2020-01-22 CA CA3127607A patent/CA3127607A1/en active Pending
- 2020-01-22 US US16/749,694 patent/US11984208B2/en active Active
- 2020-01-22 CN CN202080015935.0A patent/CN113597645A/en active Pending
- 2020-01-22 JP JP2021542448A patent/JP2022520009A/en active Pending
- 2020-01-22 JP JP2021542497A patent/JP2022518272A/en active Pending
- 2020-01-22 AU AU2020210904A patent/AU2020210904A1/en active Pending
- 2020-01-22 SG SG11202107994TA patent/SG11202107994TA/en unknown
- 2020-01-22 AU AU2020212972A patent/AU2020212972A1/en active Pending
- 2020-01-22 EP EP20708286.8A patent/EP3915121A1/en active Pending
- 2020-01-22 US US16/749,737 patent/US20200234810A1/en active Pending
- 2020-01-22 CN CN202080015844.7A patent/CN113632174A/en active Pending
- 2020-01-22 WO PCT/US2020/014549 patent/WO2020154362A1/en active Search and Examination
- 2020-01-22 EP EP20707918.7A patent/EP3915120A1/en active Pending
- 2020-01-22 CA CA3126828A patent/CA3126828A1/en active Pending
- 2020-01-22 SG SG11202107978RA patent/SG11202107978RA/en unknown
- 2020-01-22 WO PCT/US2020/014536 patent/WO2020154356A1/en active Search and Examination
-
2021
- 2021-09-22 US US17/482,135 patent/US20220020466A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CA3127607A1 (en) | 2020-07-30 |
| CN113632174A (en) | 2021-11-09 |
| JP2022520009A (en) | 2022-03-28 |
| EP3915120A1 (en) | 2021-12-01 |
| CN113597645A (en) | 2021-11-02 |
| SG11202107994TA (en) | 2021-08-30 |
| CA3126828A1 (en) | 2020-07-30 |
| WO2020154362A1 (en) | 2020-07-30 |
| US11984208B2 (en) | 2024-05-14 |
| US20200234810A1 (en) | 2020-07-23 |
| AU2020210904A1 (en) | 2021-08-05 |
| AU2020212972A1 (en) | 2021-08-05 |
| WO2020154356A1 (en) | 2020-07-30 |
| US20200294623A1 (en) | 2020-09-17 |
| JP2022518272A (en) | 2022-03-14 |
| US20220020466A1 (en) | 2022-01-20 |
| EP3915121A1 (en) | 2021-12-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11202107978RA (en) | Methods and system for the reconstruction of drug response and disease networks and uses thereof | |
| EP3638115A4 (en) | Systems and methods for integrating tomographic image reconstruction and radiomics using neural networks | |
| EP3491026A4 (en) | Human antibodies, pharmaceutical compositions and methods | |
| EP3723513A4 (en) | Probiotics and fermentation metabolites for the prevention and treatment of disease conditions in animals | |
| EP3691508B8 (en) | Imaging endoscope system and associated methods | |
| SG11202001647UA (en) | Conjugate of vegf-grab protein and drug, and use thereof | |
| IL275798A (en) | Methods for antibody drug conjugation, purification, and formulation | |
| EP3819912A4 (en) | System and method for disease diagnosis using neural network | |
| EP3723100A4 (en) | Service architecture support method and system for medical/nursing support system | |
| EP3799069A4 (en) | Two-face disease diagnosis system and method thereof | |
| IL279433A (en) | Methods and systems for monitoring organ health and disease | |
| EP3565549A4 (en) | Selective histone deacetylase inhibitors for the treatment of human disease | |
| EP3648769A4 (en) | Human microbiota derived n-acyl amides for the treatment of human disease | |
| EP3650860A4 (en) | Therapeutic drug for lipid-peroxidation-induced diseases and screening method for therapeutic drugs for lipid-peroxidation-induced diseases | |
| EP3679853A4 (en) | Diagnosis support system, endoscope system, processor, and diagnosis support method | |
| EP3730144A4 (en) | Agent for treatment of nervous system disease | |
| EP4056683A4 (en) | Brain organoid and use thereof | |
| EP4043012A4 (en) | Drug for treating artery-related diseases, and use thereof | |
| EP3844168A4 (en) | Combination drug formulations for treating patients with cardiovascular disease and associated conditions | |
| EP3799070A4 (en) | Disease diagnosis system for supporting dual class, and method therefor | |
| EP3713561A4 (en) | Pharmaceutical combinations and methods for the treatment of diabetes and associated disorders | |
| EP3634213A4 (en) | Systems and methods for visualizing patient population disease symptom comparison | |
| EP3576611A4 (en) | System and method for remote diagnosis of disease progression | |
| IL287112A (en) | Medical imaging systems and methods of using the same | |
| IL284132A (en) | Pharmaceutical compound, the method of its making and use as medicinal agent |